1. Signaling Pathways
  2. GPCR/G Protein
  3. GPR84

GPR84 (G蛋白偶联受体84)

G protein coupled receptor 84

GPR84 是一种 G 蛋白偶联中链脂肪酸受体。GPR84 是一种游离脂肪酸受体,可被饱和中链游离脂肪酸 (MCFA)(如癸酸、十一酸和月桂酸)有效激活。GPR84 是一种中链游离脂肪酸受体,在 LPS 激活的耐受性 CD14+ 单核细胞和 THP-1 细胞中,其蛋白质水平上调。

与非羟基化 MCFA 相比,2 位或 3 位羟基的 MCFA 更有效地激活 GPR84。GPR84 现在被认为是 FFA 感应 GPCR 的成员。碳链长度为 9-14 的 MCFA 可激活 GPR84,主要与百日咳毒素 (PTX) 敏感的 Gi/o 通路偶联。GPR84 应该是一种促炎受体,可能成为治疗慢性低度炎症相关疾病的一种新的、有吸引力的靶点。

GPR84 is a G protein-coupled receptor for medium-chain fatty acids. GPR84 is a receptor for free fatty acids and can be potently activated by saturated medium-chain free fatty acids (MCFAs) like decanoic acid, undecanoic acid and lauric acid. GPR84, a receptor for medium-length free fatty acids is upregulated on protein level in LPS activated tolerant CD14+ monocytes and THP-1 cells.

GPR84 is activated by MCFAs with the hydroxyl group at the 2- or 3-position more effectively than nonhydroxylated MCFAs. GPR84 is now considered to be a member of FFA-sensing GPCRs. MCFAs with carbon chain lengths of 9–14 activate GPR84, coupling primarily to a pertussis toxin (PTX)-sensitive Gi/o pathway. GPR84 should be a proinflammatory receptor and may be a novel, attractive target for treating chronic low grade inflammation associated-diseases.

GPR84 相关产品 (22):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-100775R
    Fezagepras sodium (Standard) Antagonist
    Fezagepras (sodium) (Standard)是 Fezagepras (sodium) 的分析标准品。本产品用于研究及分析应用。Fezagepras (Setogepram) sodium 是一种具有口服活性的 GPR40 激动剂和 GPR84 拮抗剂或反向激动剂。Fezagepras sodium 减轻肾,肝和胰腺纤维化。Fezagepras sodium 具有抗纤维化,抗炎和抗增殖作用。
    Fezagepras sodium (Standard)
  • HY-100775AR
    Fezagepras (Standard) Antagonist
    Fezagepras (Standard)是 Fezagepras 的分析标准品。本产品用于研究及分析应用。Fezagepras (Setogepram) 是一种具有口服活性的 GPR40 激动剂和 GPR84 拮抗剂或反向激动剂。Fezagepras 减轻肾,肝和胰腺纤维化。Fezagepras 具有抗纤维化,抗炎和抗增殖作用。
    Fezagepras (Standard)